Company: IMNN
Filing Date: 2025-03-19
Form Type: DRS
Source: 0001641172-25-000007
Chunk: 49

Company: Imunon, Inc.
Filing Date: 2025-03-19
Form: DRS
Chunk 49
---
 below. You may inspect a copy of the registration statement through the SEC’s website, as provided above.

| 29 |

| CONFIDENTIAL TREATMENT REQUESTED BY IMUNON, INC.PURSUANT TO 17 C.F.R. SECTION 200.83 |

<div align='center'>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</div>

The SEC’s rules allow us to “incorporate by reference” information into this prospectus, which means that we can disclose important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is deemed to be part of this prospectus, and subsequent information that we file with the SEC will automatically update and supersede that information.

We incorporate by reference into this prospectus and the registration statement of which this prospectus is a part the information or documents listed below (except in each case the information contained in such document to the extent “furnished” and not “filed”) that we have filed with the SEC:

| ● 
 ● | Our                                                                                                                                
 Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed on February 27, 2025;                                 
 Our                                                                                                                                
 Current Report on Form 8-K filed with the SEC on February 10, 2025 (excluding any information furnished in such reports under Item 
 2.02, Item 7.01 or Item 9.01); and                                                                                                 |
|:--|:-----------------------------------------------------------------------------------------------------------------------------------|
| ● | Description                                                                                                                        
 of Securities of the Company, incorporated herein by reference to Exhibit 4.7 to the Annual Report on Form 10-K of the Company for 
 the fiscal year ended December 31, 2024.                                                                                           |

In addition, all documents subsequently filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, prior to the termination of the offering (excluding any information furnished rather than filed), shall be deemed to be incorporated by reference into this prospectus.

Any statement contained in this prospectus or in a document incorporated or deemed to be incorporated by reference into this prospectus will be deemed to be modified or superseded for purposes hereof to the extent that a statement contained in this prospectus or any other subsequently filed document that is deemed to be incorporated by reference into this prospectus modifies or supersedes the statement. Any statement so modified or superseded will not be deemed, except as so